Literature DB >> 29380144

Contemporary Perspectives in Durable Mechanical Circulatory Support: What Did We Learn in the Last 3 Years?

Jayant Raikhelkar1, Nir Uriel2.   

Abstract

PURPOSE OF REVIEW: In this paper, we will review developments in the field of durable mechanical circulatory support over the past 3 years. RECENT
FINDINGS: The role of left ventricular assist device (LVAD) placement in non-inotrope-dependent ambulatory heart failure patients remains controversial in light of recent clinical trials. New devices are on the horizon for destination therapy in advanced heart failure patients. The concept of hemocompatibility and the calculation of hemocompatibility scores represent a novel approach to common adverse events. Recent research in mechanical circulatory support has impacted our approach to durable LVAD therapy and set the stage for further advancements in the field.

Entities:  

Keywords:  Destination therapy; Hemocompatibility; Left ventricular assist device; Mechanical circulatory support

Mesh:

Year:  2018        PMID: 29380144     DOI: 10.1007/s11886-018-0945-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  41 in total

Review 1.  Right ventricular failure after left ventricular assist devices.

Authors:  Brent C Lampert; Jeffrey J Teuteberg
Journal:  J Heart Lung Transplant       Date:  2015-07-10       Impact factor: 10.247

2.  The burden of haemocompatibility with left ventricular assist systems: a complex weave.

Authors:  Mandeep R Mehra
Journal:  Eur Heart J       Date:  2019-02-21       Impact factor: 29.983

3.  Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.

Authors:  Jerry D Estep; Randall C Starling; Douglas A Horstmanshof; Carmelo A Milano; Craig H Selzman; Keyur B Shah; Matthias Loebe; Nader Moazami; James W Long; Josef Stehlik; Vigneshwar Kasirajan; Donald C Haas; John B O'Connell; Andrew J Boyle; David J Farrar; Joseph G Rogers
Journal:  J Am Coll Cardiol       Date:  2015-10-20       Impact factor: 24.094

4.  Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices.

Authors:  Sang-Woo Pak; Nir Uriel; Hiroo Takayama; Sarah Cappleman; Robert Song; Paolo C Colombo; Sandy Charles; Donna Mancini; Linda Gillam; Yoshifumi Naka; Ulrich P Jorde
Journal:  J Heart Lung Transplant       Date:  2010-07-08       Impact factor: 10.247

5.  Assessing Frailty in Patients Undergoing Destination Therapy Left Ventricular Assist Device: Observations from Interagency Registry for Mechanically Assisted Circulatory Support.

Authors:  Lauren B Cooper; Bradley G Hammill; Larry A Allen; JoAnn Lindenfeld; Robert J Mentz; Joseph G Rogers; Carmelo A Milano; Chetan B Patel; Karen P Alexander; Adrian F Hernandez
Journal:  ASAIO J       Date:  2018 Jan/Feb       Impact factor: 2.872

6.  Frailty and outcomes after implantation of left ventricular assist device as destination therapy.

Authors:  Shannon M Dunlay; Soon J Park; Lyle D Joyce; Richard C Daly; John M Stulak; Sheila M McNallan; Véronique L Roger; Sudhir S Kushwaha
Journal:  J Heart Lung Transplant       Date:  2013-12-27       Impact factor: 10.247

7.  Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices.

Authors:  Jennifer A Frontera; Randall Starling; Sung-Min Cho; Amy S Nowacki; Ken Uchino; M Shazam Hussain; Maria Mountis; Nader Moazami
Journal:  J Heart Lung Transplant       Date:  2016-12-23       Impact factor: 10.247

8.  Unexpected abrupt increase in left ventricular assist device thrombosis.

Authors:  Randall C Starling; Nader Moazami; Scott C Silvestry; Gregory Ewald; Joseph G Rogers; Carmelo A Milano; J Eduardo Rame; Michael A Acker; Eugene H Blackstone; John Ehrlinger; Lucy Thuita; Maria M Mountis; Edward G Soltesz; Bruce W Lytle; Nicholas G Smedira
Journal:  N Engl J Med       Date:  2013-11-27       Impact factor: 91.245

9.  Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II.

Authors:  Omar Wever-Pinzon; Craig H Selzman; Stavros G Drakos; Abdulfattah Saidi; Gregory J Stoddard; Edward M Gilbert; Mohamed Labedi; Bruce B Reid; Erin S Davis; Abdallah G Kfoury; Dean Y Li; Josef Stehlik; Feras Bader
Journal:  Circ Heart Fail       Date:  2013-03-11       Impact factor: 8.790

10.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

View more
  1 in total

1.  A Novel Control Method for Rotary Blood Pumps as Left Ventricular Assist Device Utilizing Aortic Valve State Detection.

Authors:  Dmitry Petukhov; Leonie Korn; Marian Walter; Dmitry Telyshev
Journal:  Biomed Res Int       Date:  2019-12-11       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.